{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COX-2 inhibitory activity", "anti-inflammatory", "oxindoles", "\u03b1, \u03b2-unsaturated ketone"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37375225", "DateCompleted": {"Year": "2023", "Month": "06", "Day": "29"}, "DateRevised": {"Year": "2023", "Month": "07", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "06", "Day": "09"}], "Language": ["eng"], "ELocationID": ["4668", "10.3390/molecules28124668"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "28", "Issue": "12", "PubDate": {"Year": "2023", "Month": "Jun", "Day": "09"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Design, Synthesis, and Evaluation of the COX-2 Inhibitory Activities of New 1,3-Dihydro-<i>2H</i>-indolin-2-one Derivatives.", "Abstract": {"AbstractText": ["Thirty-three 1,3-dihydro-<i>2H</i>-indolin-2-one derivatives bearing \u03b1, \u03b2-unsaturated ketones were designed and synthesized via the Knoevenagel condensation reaction. The cytotoxicity, in vitro anti-inflammatory ability, and in vitro COX-2 inhibitory activity of all the compounds were evaluated. Compounds <b>4a</b>, <b>4e</b>, <b>4i</b>-<b>4j</b>, <b>and 9d</b> exhibited weak cytotoxicity and different degrees of inhibition against NO production in LPS-stimulated RAW 264.7 cells. The IC<sub>50</sub> values of compounds <b>4a</b>, <b>4i</b>, and <b>4j</b> were 17.81 \u00b1 1.86 \u03bcM, 20.41 \u00b1 1.61 \u03bcM, and 16.31 \u00b1 0.35 \u03bcM, respectively. Compounds <b>4e</b> and <b>9d</b> showed better anti-inflammatory activity with IC<sub>50</sub> values of 13.51 \u00b1 0.48 \u03bcM and 10.03 \u00b1 0.27 \u03bcM, respectively, which were lower than those of the positive control ammonium pyrrolidinedithiocarbamate (PDTC). Compounds <b>4e</b>, <b>9h</b>, and <b>9i</b> showed good COX-2 inhibitory activities with IC<sub>50</sub> values of 2.35 \u00b1 0.04 \u00b5M, 2.422 \u00b1 0.10 \u00b5M and 3.34 \u00b1 0.05 \u00b5M, respectively. Moreover, the possible mechanism by which COX-2 recognized <b>4e</b>, <b>9h</b>, and <b>9i</b> was predicted by molecular docking. The results of this research suggested that compounds <b>4e</b>, <b>9h</b>, and <b>9i</b> might be new anti-inflammatory lead compounds for further optimization and evaluation."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Guizhou University, Guiyang 550025, China."}], "LastName": "Pan", "ForeName": "Taohua", "Initials": "T"}, {"Identifier": ["0009-0001-2699-1856"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province, Chinese Academy of Sciences, Guiyang 550014, China."}], "LastName": "He", "ForeName": "Maofei", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province, Chinese Academy of Sciences, Guiyang 550014, China."}], "LastName": "Deng", "ForeName": "Lulu", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province, Chinese Academy of Sciences, Guiyang 550014, China."}], "LastName": "Li", "ForeName": "Jiang", "Initials": "J"}, {"Identifier": ["0000-0002-8973-2384"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province, Chinese Academy of Sciences, Guiyang 550014, China."}], "LastName": "Fan", "ForeName": "Yanhua", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kunming Institute of Botany, Chinese Academy of Sciences (CAS), Kunming 650201, China."}], "LastName": "Hao", "ForeName": "Xiaojiang", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province, Chinese Academy of Sciences, Guiyang 550014, China."}], "LastName": "Mu", "ForeName": "Shuzhen", "Initials": "S"}], "GrantList": [{"GrantID": "22067003", "Agency": "the National Natural Science Foundation of China", "Country": ""}, {"GrantID": "QKH-JC [2019] 1430", "Agency": "the Science and Technology Program of Guizhou Province", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "EC 1.14.99.1", "NameOfSubstance": "Cyclooxygenase 2"}, {"RegistryNumber": "0", "NameOfSubstance": "Cyclooxygenase 2 Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "indolin-2-one"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Cyclooxygenase 2"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Cyclooxygenase 2 Inhibitors"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Gao Y., Duan Y.Z. Increased COX-2 in the trigeminal nucleus caudalis is involved in orofacial pain induced by experimental tooth movement. Anat. Rec. 2010;293:485\u2013491. doi: 10.1002/ar.21078.", "ArticleIdList": ["10.1002/ar.21078", "20091889"]}, {"Citation": "Kumar A., Kour G., Chibber P., Saroch D., Kumar C., Ahmed Z. Novel alantolactone derivative AL-04 exhibits potential anti-inflammatory activity via modulation of iNOS, COX-2 and NF-kappa B. Cytokine. 2022;158:155978. doi: 10.1016/j.cyto.2022.155978.", "ArticleIdList": ["10.1016/j.cyto.2022.155978", "35921792"]}, {"Citation": "Abdelall E.K.A., Lamie P.F., Ali W.A.M. Cyclooxygenase-2 and 15-lipoxygenase inhibition, synthesis, anti-inflammatory activity and ulcer liability of new celecoxib analogues: Determination of region-specific pyrazole ring formation by NOESY. Bioorg. Med. Chem. Lett. 2016;26:2893\u20132899. doi: 10.1016/j.bmcl.2016.04.046.", "ArticleIdList": ["10.1016/j.bmcl.2016.04.046", "27158139"]}, {"Citation": "Mishra C.B., Kumari S., Prakash A., Yadav R., Tiwari A.K., Pandey P., Tiwari M. Discovery of novel methylsulfonyl phenyl derivatives as potent human Cyclooxygenase-2 inhibitors with effective anticonvulsant action: Design, synthesis, in-silico, in vitro and in vivo evaluation. Eur. J. Med. Chem. 2018;151:520\u2013532. doi: 10.1016/j.ejmech.2018.04.007.", "ArticleIdList": ["10.1016/j.ejmech.2018.04.007", "29655084"]}, {"Citation": "Zarghi A., Najafnia L., Daraee B., Dadrass O.G., Hedayati M. Synthesis of 2, 3-diaryl-1,3-thiazolidine-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors. Bioorg. Med. Chem. Lett. 2007;17:5634\u20135637. doi: 10.1016/j.bmcl.2007.07.084.", "ArticleIdList": ["10.1016/j.bmcl.2007.07.084", "17822894"]}, {"Citation": "Zebardast T., Zarghi A., Daraie B., Hedayati M., Dadrass O.G. Design and synthesis of 3-alkyl-2-aryl-1,3-thiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors. Bioorg. Med. Chem. Lett. 2009;19:3162\u20133165. doi: 10.1016/j.bmcl.2009.04.125.", "ArticleIdList": ["10.1016/j.bmcl.2009.04.125", "19447036"]}, {"Citation": "Laine L., White W.B., Rostom A., Hochberg M. COX-2 selective inhibitors in the treatment of osteoarthritis. Semin. Arthritis Rheum. 2008;38:165\u2013187. doi: 10.1016/j.semarthrit.2007.10.004.", "ArticleIdList": ["10.1016/j.semarthrit.2007.10.004", "18177922"]}, {"Citation": "Dionne R.A., Berthold C.W. Therapeutic uses of non-steroidal anti-inflammatory drugs in dentistry. Crit. Rev. Oral Biol. Med. 2001;12:315\u2013330. doi: 10.1177/10454411010120040301.", "ArticleIdList": ["10.1177/10454411010120040301", "11603504"]}, {"Citation": "Huber M.A., Terezhalmy G.T. The use of COX-2 inhibitors for acute dental pain: A second look. J. Am. Dent. Assoc. 2006;137:480\u2013487. doi: 10.14219/jada.archive.2006.0220.", "ArticleIdList": ["10.14219/jada.archive.2006.0220", "16637477"]}, {"Citation": "Nekoofar M.H., Sadeghipanah M., Dehpour A.R. Evaluation of meloxicam (A cox-2 inhibitor) for management of postoperative endodontic pain: A double-blind placebo-controlled study. J. Endod. 2003;29:634\u2013637. doi: 10.1097/00004770-200310000-00005.", "ArticleIdList": ["10.1097/00004770-200310000-00005", "14606784"]}, {"Citation": "Gupta A., Bah M. NSAIDs in the treatment of postoperative pain. Curr. Pain Headache Rep. 2016;20:62. doi: 10.1007/s11916-016-0591-7.", "ArticleIdList": ["10.1007/s11916-016-0591-7", "27841015"]}, {"Citation": "Al-Hourani B.J., Sharma S.K., Mane J.Y., Tuszynski J., Baracos V., Kniess T., Suresh M., Pietzsch J., Wuest F. Synthesis and evaluation of 1,5-diaryl-substituted tetrazoles as novel selective cyclooxygenase-2 (COX-2) inhibitors. Bioorg. Med. Chem. Lett. 2011;21:1823\u20131826. doi: 10.1016/j.bmcl.2011.01.057.", "ArticleIdList": ["10.1016/j.bmcl.2011.01.057", "21316237"]}, {"Citation": "Abdellatif K.R., Fadaly W.A., Ali W.A., Kamel G.M. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,5-diarylpyrazole derivatives. J. Enzym. Inhib. Med. Chem. 2016;31:54\u201360. doi: 10.1080/14756366.2016.1201815.", "ArticleIdList": ["10.1080/14756366.2016.1201815", "27541738"]}, {"Citation": "Dhanjal J.K., Sreenidhi A.K., Bafna K., Katiyar S.P., Goyal S., Grover A., Sundar D. Computational structure-based de novo design of hypothetical inhibitors against the anti-inflammatory target COX-2. PLoS ONE. 2015;10:e0134691. doi: 10.1371/journal.pone.0134691.", "ArticleIdList": ["10.1371/journal.pone.0134691", "PMC4524694", "26241744"]}, {"Citation": "Grosser T., Ricciotti E., FitzGerald G.A. The Cardiovascular pharmacology of nonsteroidal anti-inflammatory drugs. Trends Pharmacol. Sci. 2017;38:733\u2013748. doi: 10.1016/j.tips.2017.05.008.", "ArticleIdList": ["10.1016/j.tips.2017.05.008", "PMC5676556", "28651847"]}, {"Citation": "Elshemy H.A.H., Abdelall E.K.A., Azouz A.A., Moawad A., Ali W.A.M., Safwat N.M. Synthesis, anti-inflammatory, cyclooxygenases inhibitions assays and histopathological study of poly-substituted 1,3,5-triazines: Confirmation of regiospecific pyrazole cyclization by HMBC. Eur. J. Med. Chem. 2017;127:10\u201321. doi: 10.1016/j.ejmech.2016.12.030.", "ArticleIdList": ["10.1016/j.ejmech.2016.12.030", "28038322"]}, {"Citation": "Patrono C., Baigent C. Coxibs, Traditional NSAIDs, and cardiovascular safety post-precision: What we thought we knew then and what we think we know now. Clin. Pharmacol. Ther. 2017;102:238\u2013245. doi: 10.1002/cpt.696.", "ArticleIdList": ["10.1002/cpt.696", "28378879"]}, {"Citation": "Motika S.E., Hergenrother P.J. Re-engineering natural products to engage new biological targets. Nat. Prod. Rep. 2020;37:1395\u20131403. doi: 10.1039/D0NP00059K.", "ArticleIdList": ["10.1039/D0NP00059K", "PMC7720426", "33034322"]}, {"Citation": "Guthikonda R.N., Cama L.D., Quesada M., Woods M.F., Salzmann T.N., Christensen B.G. Modification of natural products to improve their biological properties. Pure Appl. Chem. 1987;59:455\u2013458. doi: 10.1351/pac198759030455.", "ArticleIdList": ["10.1351/pac198759030455"]}, {"Citation": "Zongru G. The modification of natural products for medical use. Acta Pharm. Sin. B. 2017;7:119\u2013126. doi: 10.1016/j.apsb.2016.06.003.", "ArticleIdList": ["10.1016/j.apsb.2016.06.003", "PMC5343118", "28303218"]}, {"Citation": "Viegas J.C., Danuello A., da Silva Bolzani V., Barreiro E.J., Fraga C.A. Molecular hybridization: A useful tool in the design of new drug prototypes. Curr. Med. Chem. 2007;14:1829\u20131852. doi: 10.2174/092986707781058805.", "ArticleIdList": ["10.2174/092986707781058805", "17627520"]}, {"Citation": "Giselle C., Costa F. Oxindoles and copper complexes with oxindole-derivatives as potential pharmacological agents. J. Braz. Chem. Soc. 2006;17:1473. doi: 10.1590/S0103-50532006000800003.", "ArticleIdList": ["10.1590/S0103-50532006000800003"]}, {"Citation": "Khetmalis Y.M., Shivani M., Murugesan S., Chandra Sekhar K.V.G. Oxindole and its derivatives: A review on recent progress in biological activities. Biomed. Pharmacother. 2021;141:111842. doi: 10.1016/j.biopha.2021.111842.", "ArticleIdList": ["10.1016/j.biopha.2021.111842", "34174506"]}, {"Citation": "Kaur M., Singh M., Chadha N., Silakari O. Oxindole: A chemical prism carrying plethora of therapeutic benefits. Eur. J. Med. Chem. 2016;123:858\u2013894. doi: 10.1016/j.ejmech.2016.08.011.", "ArticleIdList": ["10.1016/j.ejmech.2016.08.011", "27543880"]}, {"Citation": "Dey P., Kundu A., Han S.H., Kim K.S., Park J.H., Yoon S., Kim I.S., Kim H.S. Biological evaluation of exindole derivative as a novel anticancer agent against human kidney carcinoma cells. Biomolecules. 2020;10:1260. doi: 10.3390/biom10091260.", "ArticleIdList": ["10.3390/biom10091260", "PMC7565513", "32878322"]}, {"Citation": "Khan M., Yousaf M., Wadood A., Junaid M., Ashraf M., Alam U., Ali M., Arshad M., Hussain Z., Khan K.M. Discovery of novel oxindole derivatives as potent alpha-glucosidase inhibitors. Bioorg. Med. Chem. 2014;22:3441\u20133448. doi: 10.1016/j.bmc.2014.04.033.", "ArticleIdList": ["10.1016/j.bmc.2014.04.033", "24825482"]}, {"Citation": "Dreifuss A.A., Bastos-Pereira A.L., Avila T.V., Soley B.D.S., Rivero A.J., Aguilar J.L., Acco A. Antitumoral and antioxidant effects of a hydroalcoholic extract of cat\u2019s claw (Uncaria tomentosa) (Willd. Ex Roem. & Schult) in an in vivo carcinosarcoma model. J. Ethnopharmacol. 2010;130:127\u2013133. doi: 10.1016/j.jep.2010.04.029.", "ArticleIdList": ["10.1016/j.jep.2010.04.029", "20435132"]}, {"Citation": "Chaudhari P., Bari S., Surana S., Shirkhedkar A., Wakode S., Shelar S., Racharla S., Ugale V., Ghodke M. Logical synthetic strategies and structure-activity relationship of indolin-2-one hybrids as small molecule anticancer agents: An overview. J. Mol. Struct. 2022;1247:131280. doi: 10.1016/j.molstruc.2021.131280.", "ArticleIdList": ["10.1016/j.molstruc.2021.131280"]}, {"Citation": "Xu Y., Zhang X.J., Li W.B., Wang X.R., Wang S., Qiao X.P., Chen S.W. Design, synthesis and biological evaluation of indole-2-one derivatives as potent BRD4 inhibitors. Eur. J. Med. Chem. 2020;208:112780. doi: 10.1016/j.ejmech.2020.112780.", "ArticleIdList": ["10.1016/j.ejmech.2020.112780", "32883643"]}, {"Citation": "Tseng C.C., Baillie G., Donvito G., Mustafa M.A., Juola S.E., Zanato C., Massarenti C., Dall\u2019Angelo S., Harrison W.T.A., Lichtman A.H., et al. The trifluoromethyl group as a bioisosteric replacement of the aliphatic nitro group in CB (1) receptor positive allosteric modulators. J. Med. Chem. 2019;62:5049\u20135062. doi: 10.1021/acs.jmedchem.9b00252.", "ArticleIdList": ["10.1021/acs.jmedchem.9b00252", "PMC7871173", "31050898"]}, {"Citation": "Egami H., Sodeoka M. Trifluoromethylation of alkenes with concomitant introduction of additional functional groups. Angew. Chem. Int. Ed. Engl. 2014;53:8294\u20138308. doi: 10.1002/anie.201309260.", "ArticleIdList": ["10.1002/anie.201309260", "24961669"]}, {"Citation": "Feng S., Li C., Chen D., Zheng X., Yun H., Gao L., Shen H.C. Discovery of methylsulfonyl indazoles as potent and orally active respiratory syncytial Virus (RSV) fusion inhibitors. Eur. J. Med. Chem. 2017;138:1147\u20131157. doi: 10.1016/j.ejmech.2017.07.032.", "ArticleIdList": ["10.1016/j.ejmech.2017.07.032", "28772235"]}, {"Citation": "Khurshid A., Saeed A., Erben M.F., H\u00f6kelek T., Jabeen E. DFT guided substitution effect on azomethine reactive center in newly synthesized Schiff base aromatic scaffolds; syntheses, characterization, single crystal XRD, Hirshfeld surface and crystal void analyses. J. Mol. Struct. 2023;1273:134215. doi: 10.1016/j.molstruc.2022.134215.", "ArticleIdList": ["10.1016/j.molstruc.2022.134215"]}, {"Citation": "Sondhi S.M., Singh N., Kumar A., Lozach O., Meijer L. Synthesis, anti-inflammatory, analgesic and kinase (CDK-1, CDK-5 and GSK-3) inhibition activity evaluation of benzimidazole/benzoxazole derivatives and some Schiff\u2019s bases. Bioorg. Med. Chem. 2006;14:3758\u20133765. doi: 10.1016/j.bmc.2006.01.054.", "ArticleIdList": ["10.1016/j.bmc.2006.01.054", "16480879"]}, {"Citation": "Vijesh A.M., Isloor A.M., Shetty P., Sundershan S., Fun H.K. New pyrazole derivatives containing 1,2,4-triazoles and benzoxazoles as potent antimicrobial and analgesic agents. Eur. J. Med. Chem. 2013;62:410\u2013415. doi: 10.1016/j.ejmech.2012.12.057.", "ArticleIdList": ["10.1016/j.ejmech.2012.12.057", "23385092"]}, {"Citation": "Wei D., Ning L.I., Gui L.U., Yao K. Synthesis, catalytic and biological activity of novel dinuclear copper complex with Schiff base. Sci. China Ser. B. 2006;49:225\u2013229. doi: 10.1007/s11426-006-0225-8.", "ArticleIdList": ["10.1007/s11426-006-0225-8"]}, {"Citation": "John W.C. Nitric oxide in immunity and inflammation. Int. Immunopharmacol. 2001;1:1397\u20131406. doi: 10.1016/s1567-5769(01)00086-8.", "ArticleIdList": ["10.1016/s1567-5769(01)00086-8", "11515807"]}, {"Citation": "Bogdan C. Nitric oxide and the immune response. Nat. Immunol. 2001;2:907\u2013916. doi: 10.1038/ni1001-907.", "ArticleIdList": ["10.1038/ni1001-907", "11577346"]}, {"Citation": "Sungeun A., Muhammad H.S., Noh H.Y., Kim Y.J., Jin C.G., Yang C.D. Anti-inflammatory activity of ginsenosides in LPS-stimulated RAW 264.7 cells. Sci. Bull. 2015;60:773\u2013784. doi: 10.1007/s11434-015-0773-4.", "ArticleIdList": ["10.1007/s11434-015-0773-4"]}, {"Citation": "Futagami A., Ishizaki M., Fukuda Y., Seiji K., Nobuaki Y. Wound healing involves induction of Cyclooxygenase-2 expression in rat skin. Lab. Investig. 2002;82:1503\u20131513. doi: 10.1097/01.LAB.0000035024.75914.39.", "ArticleIdList": ["10.1097/01.LAB.0000035024.75914.39", "12429810"]}, {"Citation": "Yan Y.M., Zhang H.X., Liu H., Wang Y., Wu J.B., Li Y.P., Cheng Y.X. (+/\u2212)-Lucidumone, a COX-2 inhibitory ccaged fungal meroterpenoid from Ganoderma lucidum. Org. Lett. 2019;21:8523\u20138527. doi: 10.1021/acs.orglett.9b02840.", "ArticleIdList": ["10.1021/acs.orglett.9b02840", "31556302"]}, {"Citation": "Orlando B.J., Malkowski M.G. Substrate-selective inhibition of Cyclooxygeanse-2 by fenamic acid derivatives is dependent on peroxide tone. J. Biol. Chem. 2016;291:15069\u201315081. doi: 10.1074/jbc.M116.725713.", "ArticleIdList": ["10.1074/jbc.M116.725713", "PMC4946924", "27226593"]}, {"Citation": "Qin F.Y., Zhang H.X., Di Q.Q., Wang Y., Yan Y.M., Chen W.L., Cheng Y.X. Ganoderma cochlear metabolites as probes to identify a COX-2 active site and as in vitro and in vivo anti-inflammatory agents. Org. Lett. 2020;22:2574\u20132578. doi: 10.1021/acs.orglett.0c00452.", "ArticleIdList": ["10.1021/acs.orglett.0c00452", "32167308"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "4", "Day": "18"}, {"Year": "2023", "Month": "6", "Day": "2"}, {"Year": "2023", "Month": "6", "Day": "7"}, {"Year": "2023", "Month": "6", "Day": "29", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "6", "Day": "28", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "6", "Day": "28", "Hour": "1", "Minute": "31"}, {"Year": "2023", "Month": "6", "Day": "9"}], "PublicationStatus": "epublish", "ArticleIdList": ["37375225", "PMC10305287", "10.3390/molecules28124668", "molecules28124668"]}}], "PubmedBookArticle": []}